NLM Digital Collections

Search

Start Over Subjects Biomarkers ✖Remove constraint Subjects: Biomarkers Subjects Prognosis ✖Remove constraint Subjects: Prognosis Titles Hematologic malignancies: regulatory considerations for use of minimal residual disease in development of drug and biological products for treatment ✖Remove constraint Titles: Hematologic malignancies: regulatory considerations for use of minimal residual disease in development of drug and biological products for treatment

Refine by:

more »

  • Hematologic malignancies: regulatory considerations for use of minimal residual disease in development of drug and biological products for treatment1